Clinical and immunological features of 888 Brazilian systemic lupus patients from a monocentric cohort: comparison with other populations

Imagem de Miniatura
Arquivos
art_BORBA_Clinical_and_immunological_features_of_888_Brazilian_systemic_2013.PDF (119.48 KB)
Citações na Scopus
26
Tipo de produção
article
Data de publicação
2013
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS LTD
Autores
Citação
LUPUS, v.22, n.7, p.744-749, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Epidemiological studies with systemic lupus erythematosus (SLE) patients have been reported worldwide but, until now, a large evaluation had not been performed in Brazil. Therefore, we determined the clinical and immunological features of 888 SLE patients followed at our service from 2008 to 2012. The mean age at SLE onset and the mean disease duration were 29.9 +/- 9.5 years old and 14.5 +/- 8.4 years, respectively. A predominance of female gender (91.9%) and Caucasian ethnicity (69.9%) were observed. Cumulative mucocutaneous manifestations (90.7%) were most commonly identified (malar rash (83.2%), photosensitivity (76.9%)) followed by articular (87.4%), hematological (44.0%) and renal (36.9%) involvements. Antinuclear antibody was detected in all patients, followed by anti-dsDNA (35.1%), anti-Sm (21.8%) and anti-ribosomal P protein antibodies (19.8%). Additional comparison of clinical and laboratory features between genders revealed that malar rash was observed more in female SLE patients (84.5% vs. 69.4%, p = 0.001). Male lupus patients presented a higher frequency of anti-dsDNA (45.8% vs. 34.2%, p = 0.047) and a trend of more nephritis (47.2% vs. 36.0%, p = 0.059). In conclusion, we identified a high prevalence of mucocutaneous manifestations in this Brazilian SLE cohort compared to other countries, mainly malar rash that was most commonly observed in female patients. Anti-dsDNA and other specific SLE autoantibodies were also identified in a higher frequency, predominantly in the male gender.
Palavras-chave
Anti-DNA, autoantibody, gender, malar rash, systemic lupus erythematosus
URI
https://observatorio.fm.usp.br/handle/OPI/1705
Referências
  1. Al Arfaj AS, 2009, LUPUS, V18, P465, DOI 10.1177/0961203308100660
  2. Al-Maini MH, 2003, RHEUMATOL INT, V23, P186, DOI 10.1007/s00296-003-0303-6
  3. AlSaleh J, 2008, LUPUS, V17, P62, DOI 10.1177/0961203307084297
  4. Andrade RM, 2007, ARTHRITIS RHEUM, V56, P622, DOI 10.1002/art.22375
  5. Bertoli AM, 2008, ANN RHEUM DIS, V67, P500, DOI 10.1136/ard.2007.076059
  6. BLANCO FJ, 1995, REV CLIN ESP, V195, P534
  7. BONFA E, 1987, NEW ENGL J MED, V317, P265, DOI 10.1056/NEJM198707303170503
  8. BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
  9. Burling F, 2007, LUPUS, P16830
  10. CERVERA R, 1993, MEDICINE, V72, P113
  11. CHAHADE WH, 1995, LUPUS, V4, P100, DOI 10.1177/096120339500400204
  12. Cooper GS, 1998, ARTHRITIS RHEUM, V41, P1714, DOI 10.1002/1529-0131(199810)41:10<1714::AID-ART3>3.0.CO;2-U
  13. ELKON KB, 1984, J IMMUNOL, V132, P2350
  14. GHARAVI AE, 1987, ANN RHEUM DIS, V46, P1, DOI 10.1136/ard.46.1.1
  15. Ghirardello A, 2000, ANN RHEUM DIS, V59, P975, DOI 10.1136/ard.59.12.975
  16. Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
  17. Houman MH, 2004, LUPUS, V13, P204, DOI 10.1191/0961203303lu530xx
  18. Kiss E, 2007, CLIN REV ALLERG IMMU, V32, P37, DOI 10.1007/BF02686080
  19. KURATA N, 1976, ARTHRITIS RHEUM, V19, P574, DOI 10.1002/art.1780190309
  20. Lau CS, 2006, LUPUS, V15, P715, DOI 10.1177/0961203306072311
  21. Mahler M, 2006, CLIN VACCINE IMMUNOL, V13, P77, DOI 10.1128/CVI.13.1.77-83.2006
  22. MILLS JA, 1994, NEW ENGL J MED, V330, P1871, DOI 10.1056/NEJM199406303302608
  23. Mok CC, 2003, LUPUS, V12, P717, DOI 10.1191/0961203303lu451xx
  24. PISTINER M, 1991, SEMIN ARTHRITIS RHEU, V21, P55, DOI 10.1016/0049-0172(91)90057-7
  25. Pons-Estel BA, 2004, MEDICINE, V83, P1, DOI 10.1097/01.md.0000104742.42401.c2
  26. SAMANTA A, 1991, ANN RHEUM DIS, V50, P490, DOI 10.1136/ard.50.7.490
  27. Santos MJ, 2007, ACTA REUMATOL PORT, V32, P153
  28. Senna Erika Rodrigues, 2004, Journal of Rheumatology, V31, P594
  29. Tan EM, 1980, MANUAL CLIN IMMUNOLO, P866
  30. Tan TC, 2012, J RHEUMATOL, V39, P759, DOI 10.3899/jrheum.111061
  31. Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359
  32. Vila LM, 1999, LUPUS, V8, P279, DOI 10.1191/096120399678847803
  33. Vila LM, 2004, RHEUMATOLOGY, V43, P358, DOI 10.1093/rheumatology/keh048
  34. Vilá L M, 1999, P R Health Sci J, V18, P89
  35. Vilar MJP, 2002, LUPUS, V11, P528, DOI 10.1191/0961203302lu244xx

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/17